NCT01610050View on ClinicalTrials.gov

A Phase I Study of LFA102 in Japanese Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Castration-resistant Prostate Cancer, Advanced Breast Cancer
Interventions
DRUG

LFA102

Trial Locations (3)

466-8560

Novartis Investigative Site, Nagoya

650-0017

Novartis Investigative Site, Kobe

104-0045

Novartis Investigative Site, Chuo-ku

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY